The market for E-Clinical Solutions was valued at US$ 7.20 billion in 2021, and it is anticipated to increase to US$ 12.40 billion by 2027, with a CAGR of 14.0% during 2022 and 2027.
The e-clinical solutions market is made up of entities (organizations, single proprietorships, and partnerships) that sell e-clinical solutions and services utilized in the clinical development process by merging clinical technological expertise. By automating formerly time-consuming duties, e-Clinical solutions refer to the use of computerized solutions and related procedures to support clinical trial operations. From planning to submissions and data mining, e-Clinical has developed to incorporate a wide range of technology intended to assist with one or more clinical trial phases.
The medical research and new drug therapy industries are undergoing a paradigm shift away from traditional drug-based treatment and toward customized or gene-based illness management. In comparison to already available alternative therapies or medications, government reimbursement organizations, commercial insurers, and payers frequently demand novel drugs have a better therapeutic value and greater efficacy. Additionally, by controlling the standard pricing of innovative pharmaceuticals, these payers are reducing manufacturing businesses' profit margins. The E-Clinical solutions sector is concentrating on the development and marketing of software solutions that help speed up and efficiently complete clinical studies. Major pharmaceutical and biotech firms are implementing new business models to lower their overall research expenditures, which is anticipated to fuel demand for sophisticated and cutting-edge E-Clinical solutions.
Jan. 13, 2021: Bioclinica and IKCON PHARMA Partner to Deliver Best-in-Class eClinical Solutions to Pharma Industry/Sponsors--
Bioclinica, an integrated solutions provider of clinical life science and technology expertise, today announced its partnership with IKCON PHARMA (subsidiary/affiliate of IKCON TECHNOLOGIES INC), a Clinical Research Organization (CRO) & technology services company. As part of the partnership, IKCON PHARMA will have access to Bioclinica's Interactive Response Technology (IRT) and Electronic Data Capture (EDC) platform to support its customers with implementation and support of clinical protocols.
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
By Application, it is segmented into
North America dominated the eClinical solutions market in 2021, with more than 51% of total revenue. A growing target population and the incidence of lifestyle-related illnesses like diabetes and heart problems are expected to boost market expansion. The region's market is also being driven by the introduction of new products by suppliers of E-Clinical solutions and an increase in government incentives. Additionally, it is projected that the residence of notable players and the accessibility of sophisticated infrastructure will both amplify the growth of the regional market.
In Asia Pacific, the market for E-Clinical solutions is expected to grow at a healthy 15.4% CAGR over the forecast period. The demand for software solutions in the region is being fueled by the region's high unmet medical requirements and the increased prevalence of key chronic diseases like cancer, cardiovascular problems, and infectious diseases. Due to their enormous patient populations and inexpensive costs, nations like China, India, Korea, and Japan are receiving an increasing number of trials. The adoption of E-Clinical solutions in these areas has therefore increased as a result of this outsourcing.
The E-Clinical Solutions Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global E-Clinical Solutions Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 14.0% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | ERT Clinical, PAREXEL International Corporation, CRF Health, eClinical Solutions, Inc., OmniComm Systems, Inc., Medidata Solutions, Inc., DATATRAK International, Inc., MaxisIT Inc., Merge Healthcare Incorporated, Oracle Corporation, BioClinica, Inc., Bio-Optronics, Inc., Dassault Systemes, eClinicalWorks, IBM Watson Health, Anju Life Sciences Software |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 97 |
Customization Available | Yes, the report can be customized as per your needs |
What is the growth rate of E-Clinical Solutions Market?
The E-Clinical Solutions Market is growing at a CAGR of 14.0% over the next 5 years.
Who are the key players in E-Clinical Solutions Market?
ERT Clinical, PAREXEL International Corporation, CRF Health, eClinical Solutions, Inc., OmniComm Systems, Inc., Medidata Solutions, Inc., DATATRAK International, Inc., MaxisIT Inc., Merge Healthcare Incorporated, Oracle Corporation, BioClinica, Inc., Bio-Optronics, Inc., Dassault Systemes, eClinicalWorks, IBM Watson Health, Anju Life Sciences Software
What are the significant types of E-Clinical Solutions Market?
eCOA, EDC & CDMS, Clinical data integration platforms, Safety solutions, CTMS, RTSM, eTMF, Clinical Analytics Platforms
What are the major end-use applications of E-Clinical Solutions Market?
Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Consulting Service Companies, Medical Device Manufacturers, Hospitals, Academic Research Institutions
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.